{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:53:58Z","timestamp":1782330838324,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1142,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.seizure.2010.03.004","type":"journal-article","created":{"date-parts":[[2010,4,18]],"date-time":"2010-04-18T11:06:26Z","timestamp":1271588786000},"page":"296-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats"],"prefix":"10.1016","volume":"19","author":[{"given":"Giangennaro","family":"Coppola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Arcieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"D\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Messana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Signoriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pascotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2010.03.004_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eplepsyres.2004.03.006","article-title":"Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy","volume":"59","author":"Coppola","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.03.004_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1684\/j.1950-6945.2005.tb00127.x","article-title":"Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes","volume":"7","author":"Di Bonaventura","year":"2005","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2010.03.004_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000265222.24102.db","article-title":"An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy","volume":"17","author":"Striano","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2010.03.004_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2010.03.004_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1469-8749.2008.03099.x","article-title":"Levetiracetam in absence epilepsy","volume":"50","author":"Verrotti","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2010.03.004_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)90855-X","article-title":"Ucb L059, a novel anti-convulsant drug: pharmacological profile in animals","volume":"222","author":"Gower","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2010.03.004_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(95)00077-1","article-title":"Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy","volume":"22","author":"Gower","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.03.004_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90768-D","article-title":"Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats","volume":"232","author":"L\u00f6scher","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2010.03.004_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.03.004_bib10","first-page":"97","article-title":"Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern","volume":"1","author":"Woodbury","year":"1952","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.seizure.2010.03.004_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1528-1157.1969.tb03838.x","article-title":"Laboratory evaluation of antiepileptic drugs. Review of laboratory methods","volume":"10","author":"Swinyard","year":"1969","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.03.004_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0006-8993(02)03744-7","article-title":"The effect of the \u2018classic\u2019 ketogenic diet on animal seizure models","volume":"959","author":"Thavendiranathan","year":"2003","journal-title":"Brain Res"},{"issue":"Suppl 4","key":"10.1016\/j.seizure.2010.03.004_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2001.00003.x","article-title":"Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?","volume":"42","author":"Klitgaard","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.03.004_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","article-title":"Antiepileptic drug development: II. Anticonvulsant drug screening","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.03.004_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1528-1157.1995.tb02567.x","article-title":"Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl) phthalimide and prototype antiepileptic drugs in mice and rats","volume":"36","author":"Bailleux","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.03.004_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0920-1211(98)00104-1","article-title":"Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat","volume":"34","author":"Doheny","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.03.004_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0920-1211(96)00022-8","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds","volume":"25","author":"L\u00f6scher","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.03.004_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2010.03.004_bib19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1528-1157.2000.tb00115.x","article-title":"Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet","volume":"41","author":"Likhodii","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.03.004_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00148581-200608020-00004","article-title":"Valproate as a mainstay of therapy for pediatric epilepsy","volume":"8","author":"Guerrini","year":"2006","journal-title":"Paediatr Drugs"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:38:47Z","timestamp":1761010727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131110000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1059131110000580"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2010.03.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2010.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}